mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.003 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.003 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |